Bioheart, Inc. , a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announced today that it has entered into a joint venture with Magnum Cell Therapies .
http://ift.tt/1fR3tKx
http://ift.tt/1fR3tKx
No comments:
Post a Comment